Kettle Hill Capital Management, LLC Bausch Health Companies Inc. Transaction History

Kettle Hill Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Dec 08, 2022	SELL	$7.06 - $23.63 $2.25 Million - $7.52 Million	-318,366 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $4.43 Million - $5.7 Million	-204,954 Reduced 39.16%	318,366 $7.28 Million
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $2.45 Million - $3.09 Million	106,386 Added 25.52%	523,320 $14.4 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $145,657 - $174,859	5,817 Added 1.41%	416,934 $11.6 Million
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $2.63 Million - $3.13 Million	-95,749 Reduced 18.89%	411,117 $12.1 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $10.8 Million - $17.4 Million	506,866 New	506,866 $16.1 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.03B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Kettle Hill Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Kettle Hill Capital Management, LLC with notifications on news.